Dubaï, Émirats arabes unis - lundi, 08. juin 2026
La Chambre de commerce de Dubaï, l’une des trois entités réunies sous l’égide de Dubai Chambers, a achevé, avec succès, une série de missions commerciales en Afrique, au cours desquelles 1 460 rencontres d’affaires bilatérales ont été organisées au Ghana, en Éthiopie et en Afrique du Sud.
Ces missions ont permis de mettre en relation des entreprises établies à Dubaï avec des partenaires stratégiques à travers le continent africain. Elles ont réuni 45 sociétés basées à Dubaï, représentant un large éventail de secteurs d’activité. Conçues pour accompagner l’expansion internationale des entreprises opérant depuis Dubaï, ces rencontres ont favorisé l’identification de nouvelles perspectives de croissance et contribué au renforcement des relations commerciales et des partenariats d’investissement avec les acteurs économiques africains.
La Chambre a organisé 276 rencontres d’affaires bilatérales au Ghana, 510 en Éthiopie et 674 en Afrique du Sud. Dans le cadre de ces missions, elle a également tenu des forums économiques dans chacun de ces marchés, réunissant au total 1 721 participants, parmi lesquels figuraient de hauts responsables gouvernementaux, des dirigeants d’entreprise et des représentants du secteur privé local.
S.E. Mohammad Ali Rashed Lootah, président-directeur général de Dubai Chambers, a déclaré : «L’Afrique constitue aujourd’hui l’une des régions les plus dynamiques de l’économie mondiale et offre d’importantes opportunités en matière de commerce, d’investissement et de partenariats entre acteurs du secteur privé. À travers ces missions, nous favorisons l’établissement de liens directs entre les entreprises de Dubaï et leurs homologues sur les marchés africains, leur permettant d’identifier de nouvelles perspectives de développement, de nouer des partenariats stratégiques et de contribuer à une croissance économique mutuellement bénéfique».
Ces missions commerciales ont été organisées dans le cadre des efforts déployés par Dubaï pour renforcer davantage ses relations commerciales et d’investissement avec le continent africain. En 2025, les échanges commerciaux non pétroliers entre Dubaï et l’Afrique ont dépassé 145,9 milliards de dollars américains, enregistrant une progression annuelle de 51%. Sur la période de dix ans comprise entre 2016 et 2025, le volume total des échanges non pétroliers entre Dubaï et l’Afrique a atteint près de 657 milliards de dollars américains, soit une hausse d’environ 325% sur la décennie.
Cette dynamique de croissance se reflète également dans l’évolution du nombre d’entreprises africaines membres de la Chambre de commerce de Dubaï. En 2025, 30 409 entreprises africaines étaient enregistrées en tant que membres actifs, ce qui représente une augmentation de 14,3% par rapport à l’année précédente.
La Chambre de commerce internationale de Dubaï dispose actuellement de sept bureaux de représentation à travers l’Afrique, qui jouent un rôle essentiel dans l’identification d’opportunités d’affaires, le renforcement des relations économiques et le développement des échanges commerciaux et des flux d’investissement entre Dubaï et les marchés africains.
À propos de la Chambre de commerce de Dubaï
Fondée en 1965, la Chambre de commerce de Dubaï œuvre au service des intérêts de la communauté d’affaires de l’émirat. Elle contribue à renforcer un environnement économique compétitif et propice à la croissance, tout en consolidant le positionnement de Dubaï en tant que pôle pionnier d’affaires mondial.
Le texte du communiqué issu d’une traduction ne doit d’aucune manière être considéré comme officiel. La seule version du communiqué qui fasse foi est celle du communiqué dans sa langue d’origine. La traduction devra toujours être confrontée au texte source, qui fera jurisprudence.
Permalink
https://www.aetoswire.com/fr/news/dcc08062026f
Contacts
Mohamad Mouzehem
mohamad.mouzehem@dubaichamber.com
Tuesday, June 9, 2026
Dubai Chamber of Commerce organises 1,460 B2B meetings during trade missions to Africa
Dubai, United Arab Emirates - Monday, 08. June 2026
Dubai Chamber of Commerce, one of the three chambers operating under the umbrella of Dubai Chambers, has successfully concluded a series of trade missions to Africa, organising a total of 1,460 bilateral business meetings in Ghana, Ethiopia, and South Africa.
The missions brought together companies from Dubai with potential partners across the continent, with the participation of 45 Dubai-based companies operating across diverse sectors. The meetings were designed to support the international growth of companies operating in Dubai, unlock new business opportunities, and strengthen trade and investment partnerships with African business communities.
The chamber organised 276 bilateral business meetings in Ghana, 510 meetings in Ethiopia, and 674 meetings in South Africa. As part of the missions, Dubai Chamber of Commerce also hosted business forums in each market, attracting a total of 1,721 participants including senior officials, business leaders, and representatives of local companies.
H.E. Mohammad Ali Rashed Lootah, President and CEO of Dubai Chambers, commented: “Africa represents one of the most dynamic regions in the global economy and offers significant opportunities for trade, investment, and private sector partnerships. Through these missions, we are creating direct connections between companies in Dubai and their counterparts across African markets, enabling businesses to explore new opportunities, build strategic partnerships, and contribute to mutual economic growth.”
The trade missions were organised as part of Dubai’s drive to further strengthen trade and investment ties with Africa. Non-oil trade between Dubai and Africa exceeded US$ 145.9 billion in 2025, achieving 51% year-on-year growth. During the 10 years from 2016 to 2025, Dubai’s non-oil trade with Africa amounted to around US$ 657 billion, increasing by around 325% over the decade.
This growing momentum is also reflected in Dubai Chamber of Commerce’s membership, with the number of African companies registered as active members reaching 30,409 in 2025, representing 14.3% year-on-year growth.
Dubai International Chamber currently operates seven representative offices across Africa, which play a vital role in identifying opportunities, strengthening business ties, and supporting the growth of trade and investment flows between Dubai and African markets.
About Dubai Chamber of Commerce
Established in 1965, Dubai Chamber of Commerce continues to advance the interests of the business community in Dubai, support a stimulating business environment, and promote the emirate as a global business hub.
Permalink
https://www.aetoswire.com/en/news/DCC08062026E
Contacts
Mohamad Mouzehem
mohamad.mouzehem@dubaichamber.com
Dubai Chamber of Commerce, one of the three chambers operating under the umbrella of Dubai Chambers, has successfully concluded a series of trade missions to Africa, organising a total of 1,460 bilateral business meetings in Ghana, Ethiopia, and South Africa.
The missions brought together companies from Dubai with potential partners across the continent, with the participation of 45 Dubai-based companies operating across diverse sectors. The meetings were designed to support the international growth of companies operating in Dubai, unlock new business opportunities, and strengthen trade and investment partnerships with African business communities.
The chamber organised 276 bilateral business meetings in Ghana, 510 meetings in Ethiopia, and 674 meetings in South Africa. As part of the missions, Dubai Chamber of Commerce also hosted business forums in each market, attracting a total of 1,721 participants including senior officials, business leaders, and representatives of local companies.
H.E. Mohammad Ali Rashed Lootah, President and CEO of Dubai Chambers, commented: “Africa represents one of the most dynamic regions in the global economy and offers significant opportunities for trade, investment, and private sector partnerships. Through these missions, we are creating direct connections between companies in Dubai and their counterparts across African markets, enabling businesses to explore new opportunities, build strategic partnerships, and contribute to mutual economic growth.”
The trade missions were organised as part of Dubai’s drive to further strengthen trade and investment ties with Africa. Non-oil trade between Dubai and Africa exceeded US$ 145.9 billion in 2025, achieving 51% year-on-year growth. During the 10 years from 2016 to 2025, Dubai’s non-oil trade with Africa amounted to around US$ 657 billion, increasing by around 325% over the decade.
This growing momentum is also reflected in Dubai Chamber of Commerce’s membership, with the number of African companies registered as active members reaching 30,409 in 2025, representing 14.3% year-on-year growth.
Dubai International Chamber currently operates seven representative offices across Africa, which play a vital role in identifying opportunities, strengthening business ties, and supporting the growth of trade and investment flows between Dubai and African markets.
About Dubai Chamber of Commerce
Established in 1965, Dubai Chamber of Commerce continues to advance the interests of the business community in Dubai, support a stimulating business environment, and promote the emirate as a global business hub.
Permalink
https://www.aetoswire.com/en/news/DCC08062026E
Contacts
Mohamad Mouzehem
mohamad.mouzehem@dubaichamber.com
Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Support the Company’s Advancement Toward Commercialization
CHESTERBROOK, Pa. - Monday, 08. June 2026
Ulf Wiinberg appointed to Board of Directors
William “Bill” MacKenzie hired as Senior Vice President – Finance
(BUSINESS WIRE) -- Neuraptive Therapeutics today announced the appointment of Ulf Wiinberg to its Board of Directors and William “Bill” MacKenzie as Senior Vice President – Finance.
Mr. Wiinberg is a seasoned biotechnology, pharmaceutical and healthcare industries executive with an extensive global career. As a member of the Board of Directors, he will contribute strategic guidance and industry expertise to support the Company’s development and commercialization strategy.
Mr. Wiinberg’s experience includes serving as CEO of X-Vax Technology, Inc. from 2017 until 2024 and prior to that, he was CEO of Lundbeck from 2008 until 2014. From 2002 to 2008, he was a member of Wyeth’s Management Committee and during this time, he was Worldwide President of Wyeth Consumer Healthcare from 2002 to 2005, and President of Europe/Middle East/Africa until 2008, when Wyeth was acquired by Pfizer.
Ulf serves as a director on several company boards including UCB, a global biopharmaceutical company headquartered in Brussels, Belgium, Alfa Laval AB, Lund, Sweden, SIGRID Therapeutics AB, Stockholm Sweden and MiNK Therapeutics, Inc., Lexington, MA.
Commenting on his appointment, Mr. Wiinberg said, “I look forward to working collaboratively with my fellow directors and the management team at this exciting time in Neuraptive’s journey as the company continues to advance its important work to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.”
Bill MacKenzie, Senior Vice President-Finance, will lead the enterprise finance function and the development of the company's operational infrastructure. Since March 2025, Bill served as consultant, Head of Finance at Neuraptive. He brings over a decade of biotech financial leadership, progressing from senior accountant to executive roles including Head of Accounting and Head of FP&A for revenue, commercial, and R&D. Bill's career includes positions at Sage Therapeutics from 2022 to 2024, Prelude Therapeutics from 2021 to 2022, LifeScan from 2020 to 2021, Zyla Life Sciences from 2015 to 2020, spanning public, private, and PE-backed environments. Bill’s background includes multiple FDA-approved products and navigating complex corporate restructurings.
“We are thrilled to welcome Bill and Ulf to the company,” said Bob Radie, Chairman of the Board and Chief Executive Officer of Neuraptive. “Bill’s deep financial expertise and leadership will be instrumental as we continue to progress NTX-001 toward commercialization, while Ulf’s global industry experience and strategic insight will provide immense value to our Board and leadership team. “
About Neuraptive
Neuraptive Therapeutics, Inc. is a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries. The company’s headquarters are in Chesterbrook, PA. For more information, see www.neuraptive.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260608270654/en/
Permalink
https://www.aetoswire.com/en/news/0806202655517
Contacts
IR@neuraptive.com
or
+1-484-787-3203
DFNS Rebrands as the Core Banking Platform for Digital Assets
(BUSINESS WIRE)--DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/
Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account.
“DFNS was built on a simple assumption. Most financial flows will move from ledgers to blockchains,” said Clarisse Hagège, CEO of DFNS. “Institutions don’t need a wallet. They need a new core system to manage both classic assets and digital assets. We are that infrastructure layer between a company's existing systems and the blockchains where digital assets now move, settle, and generate value.”
DFNS sits between an institution’s business logic and the services powering onchain finance. Its platform brings together wallet-as-a-service capabilities, key management, transaction processing, data integrity, governance and policy enforcement, workflow automations, treasury controls, tokenization engines, compliance integrations, and audit logs in one system across 100+ blockchains and third-parties.
Unlike providers that combine infrastructure with custody, brokerage, or regulated financial services, DFNS operates as a pure technology platform. It does not custody assets, face end clients, or compete with customers. Its role is to help institutions preserve control while modernizing their operations, onchain.
The rebrand includes a new visual identity, website, and product narrative organized around the critical workflows institutions run: wallets, transactions, policies, approvals, compliance, issuance, assets, treasury, and more. Existing APIs, contracts, integrations, and SLAs are unaffected.
DFNS is trusted by 400+ institutions and fintechs globally. The company has secured over €100B in assets, processes roughly 1% of the global stablecoin volume every month, and has had zero security breaches or key losses since 2020.
Learn more at dfns.co.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260603859127/en/
Permalink
https://www.aetoswire.com/en/news/5062026554833
Contacts
Press contact
Christopher Grilhault des Fontaines (Co-CEO)
press@dfns.co
Seequent and Cascade Institute Partner to Map Canada’s Deep Geothermal Resources
CALGARY, Alberta -
State-of-the-art thermal model will provide a nationwide view of subsurface heat to accelerate Canada’s clean energy goals
(BUSINESS WIRE)--Seequent, The Bentley Subsurface Company, and the Cascade Institute today announced a collaboration to develop a Canadian Thermal Model. This landmark national initiative will reveal Canada’s deep geothermal resources and accelerate the development of renewable energy. The announcement comes on the opening day of the world’s biggest geothermal event, the World Geothermal Congress, being held in Calgary from 8 to 11 June.
As investment in geothermal energy surges globally as a reliable, always-on clean power source, the Canadian Thermal Model will create a comprehensive national view of deep heat resources using novel machine learning methods to address a long-standing challenge for the sector: limited subsurface data coverage. Seequent is providing access to its world-leading geophysics software to accelerate research into the Earth’s subsurface.
This initiative advances knowledge of Canada’s geothermal energy reserves by integrating geologic and geophysical datasets into InterPIGNN machine learning algorithm for deep heat modelling. By improving confidence in where geothermal resources are located, the model provides a critical foundation to inform investment, policy planning, and project development nationwide.
“Canada has a significant opportunity to advance geothermal when the need for reliable, always-on clean energy has never been greater,” said Jeremy O’Brien, Energy Segment Director, Seequent. “Realizing that potential starts with greater subsurface certainty and making data accessible to key stakeholders. Combining this access with best-in-class geophysics enables more accurate mapping of heat at depth. The Canadian Thermal Model brings these elements together to create a national view of deep geothermal resources, helping to reduce risk, guide investment, and accelerate development.”
The Cascade Institute, a think tank at Royal Roads University focused on high-impact interventions to address humanity’s deepest problems, will lead the project through its Deep Geothermal program. Cascade Institute specialists, working with a team of geoscientists and research partners, including Simon Fraser University, 400C Energy, and the Geological Survey of Canada Pacific Division, will develop the model using data integration workflows supported by Seequent’s Oasis montaj geophysics software. Seequent’s technology will process and visualize the data required to inform energy markets on resource availability and development costs.
“Canada has world-class subsurface expertise and a growing opportunity to lead in geothermal,” said Thomas Homer-Dixon, Executive Director of the Cascade Institute. “This project will provide a foundational resource to demonstrate the technical and economic viability of geothermal energy at scale.”
The Canadian Thermal Model reflects a broader industry shift toward data-driven geothermal development, including next-generation technologies and national-scale resource assessment. It also underscores the growing importance of partnerships between research institutions, technology providers, and the wider energy sector to scale geothermal from opportunity to infrastructure.
Seequent supports more than 60% of the world’s geothermal power generation, with experience spanning next-generation projects such as Fervo Energy’s Cape Station in Utah, and long-established operations including Ormat’s global footprint, reflecting deep expertise that drives the sector forward.
Today, Seequent and the Cascade Institute will present The Next Frontier: Exploring the Potential of Canada’s Deep Geothermal Resources at the World Geothermal Congress. The interactive discussion, hosted at the Seequent booth at 1:30 PM, will provide an in-depth examination of the technical challenges and opportunities associated with deep geothermal systems.
About Seequent
Seequent, The Bentley Subsurface Company, helps organizations to understand the underground, giving them the confidence to make better decisions faster. Seequent builds world-leading technology that is at the forefront of Earth sciences, transforming the way our customers work. Every day we help them develop critical mineral resources more sustainably, design and build better infrastructure, source renewable energy, and reduce their impact on the environment.
Seequent operates in 150+ countries while proudly maintaining headquarters in New Zealand.
About the Cascade Institute
The Cascade Institute uses complexity science to design workable interventions to humanity’s most pressing problems. Cascade researchers identified geothermal energy as a key component of a future-fit global energy system, and assembled an Ultradeep Geothermal team focused on aligning technology, policy, and finance to accelerate geothermal deployment, starting in Canada and scaling globally.
Newsroom: https://www.seequent.com/company/news-media/
Seequent on LinkedIn.
© 2026 Bentley Systems, Incorporated. Bentley, Seequent, the Seequent logo, and Oasis montaj are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260608741816/en/
Permalink
https://www.aetoswire.com/en/news/8062026555166
Contacts
Press Contact:
Dina Zaid, dina.zaid@seequent.com, Senior External Communications Advisor, Seequent
Colin Hunter, hunter@cascadeinstitute.org, Communications Lead, Cascade Institute
Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy
LJUBLJANA, Slovenia - Monday, 08. June 2026 AETOSWire
(BUSINESS WIRE) -- Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared.
"PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the leading facilities in the world," said Mark Pleško, CEO of Cosylab. "Our partners have been clear on what matters most for particle therapy: physics accuracy they can defend, clinical confidence at the point of plan approval, and a platform built to grow with AI and adaptive workflows. We designed PlanOne™ around those three priorities, and we'll keep developing it together with the clinical community that helped shape it."
Physics-accurate, radiobiologically informed planning
PlanOne™ is built on a GPU-accelerated Monte Carlo dose engine for particle therapy, which serves as the physical foundation for accurate LET calculation and variable RBE modelling*. Clinical teams can plan with confidence and can review plans within a single planning workflow.
Full control over plan robustness
PlanOne™ provides comprehensive user-defined robust optimization, analysis and evaluation. Beyond the worst-case scenario approach, PlanOne™ supports an all-scenario scheme across the full set of user-defined scenarios simultaneously, resulting in treatment plans that reflect physical reality without compromising the plan’s robustness.
One environment. The OIS you already have.
Contouring, planning, and review take place within a single environment, and purpose-built tools support the demands of proton and heavy-ion treatment planning. PlanOne™ integrates with existing oncology information systems, helping preserve established workflows while reducing the need for data migration.
About Cosylab
Cosylab is a software and control systems company headquartered in Ljubljana, Slovenia. With over 20 years of experience and more than 1,000 projects across particle accelerators, radiation therapy devices, and oncology information systems, Cosylab develops complex software for the world's most technically demanding environments. PlanOne™ V1.0 is Cosylab's FDA 510(k) cleared treatment planning system for particle therapy.
PlanOne™ V1.0 is FDA 510(k) cleared. Items marked with * are in preparation for regulatory submission or under development; not yet available for sale and/or clinical use in any market. Market availability is subject to regulatory approval. PlanOne is a trademark of Cosylab d.d., registered in the United States and the European Union.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260607163098/en/
Permalink
https://www.aetoswire.com/en/news/0806202655508
Contacts
For more information, contact:
Media contact: Petra Balažic, petra.balazic@cosylab.com
Product info: cosylab.com/planone, planone@cosylab.com
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
- £175m for first Haleon manufacturing site in Madhya Pradesh, central India
- Fast-growing India key to Haleon reaching one billion more consumers by 2030
- India’s consumer health market to reach over £23bn by 20301
- Accelerated rural distribution to access 3 million outlets
- Affordable Sensodyne packs and investment to double ‘last-mile’ reach in rural areas
(BUSINESS WIRE) -- Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia.
Building capacity to meet rising demand
The new site, which is well-positioned in the middle of the country and close to some of India’s most renowned technical colleges, marks an important step in the delivery of Haleon’s Win as One strategy. Win as One focuses on unlocking growth, driving productivity and transforming the company’s culture. Strengthening its in-house supply chain capabilities will enable Haleon to be more resilient and able to adapt faster to consumer needs.
Haleon’s investment in India reflects the clear, structural shift towards prevention and daily self-care, with the country’s consumer health market expected to reach over £23 billion by 2030. India is already one of Haleon’s largest oral health markets and this latest investment will accelerate access to its portfolio of trusted, science-backed brands including Sensodyne and parodontax across rural communities, with ambitions to reach more than three million outlets by 2030.
The investment is in line with Haleon’s capital allocation priorities as outlined at the company’s Capital Markets Day in 2025.
Reaching underserved communities at scale
Rural India is home to around 65% of the country’s population3, spread across more than 650,000 villages4, where unmet oral health needs remain significant. Access to dental care remains highly limited in rural India, where a single dentist may serve around 250,000 people5. With as few as 1 in 7 people in rural communities6 visiting a dentist each year, many live with untreated conditions like tooth decay or sensitivity for years. With many not currently using specialist toothpaste such as Sensodyne, recommended by healthcare professionals, there is a significant opportunity to address unmet consumer needs.
With many households reliant on daily wages and increasingly value conscious, Haleon will also be rolling out access to high-quality, science based oral health products made with trusted ingredients through lower-cost, small-format toothpaste packs – including its 20-rupee Sensodyne pack – across significantly more towns and villages.
With sales and distribution teams now working directly into Haleon’s leadership, there is significant opportunity to transform how products reach consumers in new and innovative ways – supported by the recruitment of more than 500 people to its sales teams over the last 12 months.
‘Last-mile’ investment to build awareness and access
Haleon is also investing in ‘last-mile’ capabilities, doubling frontline teams on motorbikes who are equipped with testing kits, samples and diagnostic tools and deployed to rural areas, which are often beyond the reach of traditional retail and pharmacies. Simple diagnostic tools, such as ‘chill tests’ – where consumers assess sensitivity by drinking cold water - help consumers recognise symptoms they may have had for years and connect them with science-backed treatment, often for the first time.
The company is also improving access by engaging rural communities directly through education, with its network of mobile oral health literacy vans. These Sensodyne-branded vans are designed to turn local squares and marketplaces into community hubs for oral health awareness, sensitivity and gum health checks, and immediate access to products.
Brian McNamara, CEO, Haleon, said: “India is a key strategic market for Haleon and an important driver of our long-term growth. This investment strengthens our local manufacturing footprint and expands our reach in one of the world’s fastest-growing consumer health markets. By increasing access to our trusted brands and building our capabilities on the ground, we are well positioned to capture the significant opportunities ahead.
“We aim to expand access to better everyday health for more than 300 million additional consumers in India. This will be key to achieving our broader ambition to reach one billion more consumers globally by 2030.”
The new manufacturing facility was marked by a groundbreaking ceremony and a meeting between Haleon management and the Chief Minister of Madhya Pradesh this week. It will create up to 500 jobs, strengthen local capabilities and support long-term economic development, reinforcing Haleon’s ambition to be an employer of choice in the country. It is expected to open in early 2028 with supply commencing the following year.
Notes to editors Q&A
Why is Haleon investing in India?
India is one of Haleon’s fastest growing markets and key to achieving its ambition to reach one billion more consumers by 2030. The country’s consumer health market is forecast to reach over £23 billion by 2030, driven by rising awareness and adoption of self-care. Significant unmet health needs in rural areas, where access to care remains limited and many consumers do not yet use specialist products, create substantial headroom for growth and an opportunity to expand access to everyday health.
How much is Haleon investing in India, and how will this investment be phased?
Haleon is investing around £175 million of capital expenditure in a new oral health manufacturing site in Madhya Pradesh. This investment will be phased across the 2025 – 2029 period. The site is expected to open in early 2028, with supply commencing the following year, supporting the company’s long-term growth plans in India. The investment is in line with Haleon’s capital allocation priorities as outlined at the company’s Capital Markets Day in 2025.
How will this investment support Haleon’s growth strategy?
The investment supports Haleon’s Win as One strategy by strengthening in-house supply chain capabilities and enabling faster response to consumer needs. It also forms part of Haleon’s ‘Build for Tomorrow’ programme, which is transforming Haleon’s global supply chain to meet mid- to long-term needs, including through investments in key growth markets such as India and China.
Will the new manufacturing site support exports to other markets?
The new site focuses on meeting growing demand within India, one of our fastest-growing markets, while also serving other parts of Asia. The site strengthens local manufacturing capabilities and supply chain resilience, while forming part of our broader global supply chain transformation.
How does this investment strengthen Haleon’s presence in India?
We actively invest in markets where we see opportunities to drive innovation and create value. This investment strengthens Haleon’s capabilities in India by expanding local manufacturing and building a more localised, resilient supply network closer to consumers. It enhances agility to meet growing demand - particularly in underserved and rural communities - while supporting the company’s broader efforts to optimise and transform its global supply chain.
How many people does Haleon employ in India, and will this investment create jobs?
Haleon already employs a significant workforce across India. The new manufacturing site will create 500 jobs and strengthen local capabilities. In addition, the company has recruited more than 500 people into its sales teams over the last 12 months to support expanded distribution.
How does this announcement build on Haleon’s existing presence in India?
Since becoming a standalone company in 2022, Haleon has redefined its presence in India - building its own end-to-end dedicated salesforce and distribution network. This investment builds on that foundation, strengthening route-to-market and accelerating rural outreach to reach more underserved communities.
Why have you selected Madhya Pradesh as the location for the new site?
Madhya Pradesh is well-positioned in the centre of the country with the site selected due to its close proximity to infrastructure, higher education, logistics, talent and incentives.
Where does India sit within Haleon’s global operating model?
Haleon’s new operating model – announced early this year - established India Subcontinent as a distinct Operating Unit, reporting directly into the Chief Executive, reflecting the scale and growth potential of the market and reinforcing the strategic importance of this investment.
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.
For more information, please visit www.haleon.com
1 Source: IQVIA Market Prognosis (consumer health), India, 2024–2030 estimates.
2 £175m reflects gross Investment at 1 Pound = INR 115
3 Press Release Page | Press Information Bureau
4 Press Release: Press Information Bureau
5 (PDF) An Overview of Oral Health in India: Current Scenario and Challenges
6 https://pmc.ncbi.nlm.nih.gov/articles/PMC12220351/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260608753094/en/
Permalink
https://www.aetoswire.com/en/news/0806202655510
Contacts
Philippa Keir - philippa.l.keir@haleon.com - +447969271455
Victoria Durman - victoria.a.durman@haleon.com - +447894505730
Subscribe to:
Posts (Atom)